Loading...
Chemical structure of Nastorazepide

GC19258

Nastorazepide

Also known as 3-[[(3R)-1-cyclohexyl-5-(3,3-dimethyl-2-oxobutyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]carbamoylamino]benzoic acid

Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity

ChemicalCAS209219-38-5MW520.62FormulaC29H36N4O5
CAS number
209219-38-5
Molecular weight
520.62
Formula
C29H36N4O5
Solubility
DMSO ： ≥ 32 mg/mL (61·47 mM)
InChIKey
VIJCCFFEBCOOIE-JOCHJYFZSA-N
Catalogue number
GC19258
Brand
GLPBIO
Computed properties PubChem CID 9872609 · XLogP 4.4 · TPSA 119 Ų · H-bond donors 3
XLogP
4.4
TPSA
119 Ų
H-bond donors
3
H-bond acceptors
6
Rotatable bonds
7
Heavy atoms
38

SMILES CC(C)(C)C(=O)CN1C2=CC=CC=C2N(C[C@H](C1=O)NC(=O)NC3=CC=CC(=C3)C(=O)O)C4CCCCC4

Computed descriptors from PubChem (CID 9872609), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.